Immunosuppressive agents and plasmapheresis in immunological disorders

Area of Science:

• Immunology
• Rheumatology
• Pharmacology

Background:

• Plasmapheresis (PA) emerged as a treatment for immune-mediated diseases.
• Initial claims of PA as a cure-all were not sustained.
• PA's efficacy is limited without concurrent immunosuppressive therapy.

Purpose of the Study:

• To review the immunoregulatory effects of immunosuppressive agents.
• To discuss the role of these agents when combined with PA.
• To focus on the treatment of rheumatological disorders.

Main Methods:

• Literature review of immunoregulatory effects.
• Analysis of studies combining PA and immunosuppressants.
• Focus on rheumatological applications.

Main Results:

• PA alone lacks sustained therapeutic impact.
• Immunosuppressive drugs are necessary for maintaining PA's effects.
• Combination therapy shows promise in rheumatological treatment.

Conclusions:

• PA is not a standalone treatment for immune-mediated diseases.
• Concomitant use of immunosuppressive drugs enhances PA's therapeutic maintenance.
• Combination therapy is key for managing rheumatological disorders effectively.